Related Experiment Videos
Prolactin receptor signaling during platelet activation.
H Wallaschofski1, A Kobsar, M Koksch
1Department of Internal Medicine I, University of Erlangen, Germany.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme
|June 5, 2003
Summary
High prolactin levels are linked to an increased risk of venous thromboembolism (VTE). This study found prolactin enhances platelet activation, suggesting a new mechanism for thrombosis and potential therapeutic targets.
Area of Science:
- Endocrinology
- Hematology
- Molecular Biology
Background:
- Prolactin is a platelet coactivator, potentiating ADP-induced platelet activation.
- The link between hyperprolactinemia and venous thromboembolism (VTE) remains under-investigated.
- Prolactin signaling pathways in platelets require elucidation.
Purpose of the Study:
- To investigate the association between hyperprolactinemia and VTE.
- To explore prolactin receptor signaling in platelet activation.
- To identify molecular mechanisms underlying prolactin-mediated thrombosis.
Main Methods:
- Measured plasma prolactin levels in healthy subjects and VTE patients.
- Investigated prolactin receptor signaling in ADP-stimulated platelets.
- Focused on G-protein-regulated signaling pathways and protein kinase C.
Main Results:
- Patients with VTE showed significantly elevated plasma prolactin levels.
- Prolactinoma patients had a higher incidence of VTE compared to the general population.
- The short isoform of prolactin receptors was found on platelets, influencing Gq-protein pathways and activating protein kinase C.
Conclusions:
- Hyperprolactinemia may be a novel risk factor for VTE.
- Prolactin's thrombogenic effect is likely mediated by enhanced platelet reactivity.
- Understanding prolactin signaling in platelets could lead to new antithrombotic therapies.